Target intelligence / Profile preview

Long intergenic non-protein coding RNA 1913 (LINC01913)

Target
LINC01913
Molecular classification
Long intergenic non-coding RNA (lincRNA), Long non-coding RNA (lncRNA), Other (not a receptor, enzyme, transporter, etc.)
01

Overview

Long intergenic non-protein coding RNA 1913 (LINC01913) is a non-protein-coding intergenic transcript, part of the long non-coding RNA family, expressed from chromosome 2p21. Recent clinical research identifies LINC01913 as a novel lncRNA with oncogenic properties, correlating its overexpression in gastric cancer tumors to lymph node metastasis, deeper tumor invasion, and poorer overall survival in affected patients. Functional evidence links LINC01913's regulatory roles to the PI3K-AKT and EMT pathways, which are critical in cancer cell proliferation and metastasis. Although LINC01913 is not a traditional therapeutic target, research highlights its potential value as a clinical biomarker for diagnosis and prognosis in gastro-intestinal malignancies, subject to ongoing validation in multicenter studies.

Other names
LINC01913
02

Mechanism of action

Not applicable; current data do not indicate a direct mechanism for drug action against LINC01913, though its regulation may intersect PI3K-AKT and EMT pathways, suggesting possible indirect modulation as understanding evolves.

03

Biological functions

Putative oncogenic regulatory rolePossible involvement in epithelial-to-mesenchymal transition (EMT)Regulation of gene expression (notably via PI3K-AKT signaling)Correlation with tumor progression and metastasis in gastric cancer
04

Disease associations

Cancer (particularly gastric cancer; also explored in context of other gastrointestinal malignancies)May be implicated in tumor progression, metastasis, and EMT
05

Safety considerations

No safety concerns or therapeutic challenges are directly described for LINC01913 targeting, as it is not a current drug target. Safety information would be relevant if any interventions aimed to modulate its expression.
06

Biomarkers

Elevated LINC01913 expression in gastric cancer associated with poor prognosis and reduced overall survivalProposed diagnostic and prognostic biomarker for gastric cancer progression and metastasis

Beyond the preview

Go deeper on Long intergenic non-protein coding RNA 1913 (LINC01913).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Long intergenic non-protein coding RNA 1913 (LINC01913).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call